Filing Details
- Accession Number:
- 0001209191-19-048225
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-09-04 16:42:58
- Reporting Period:
- 2019-08-30
- Accepted Time:
- 2019-09-04 16:42:58
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1446847 | Ironwood Pharmaceuticals Inc | IRWD | Pharmaceutical Preparations (2834) | 043404176 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1478448 | A Thomas Mccourt | C/O Ironwood Pharmaceuticals, Inc. 301 Binney Street Cambridge MA 02142 | President | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Class A Common Stock | Acquisiton | 2019-08-30 | 90,000 | $4.88 | 199,739 | No | 4 | M | Direct | |
| Class A Common Stock | Acquisiton | 2019-08-30 | 130,000 | $4.88 | 329,739 | No | 4 | M | Direct | |
| Class A Common Stock | Disposition | 2019-08-30 | 220,000 | $9.24 | 109,739 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Class A Common Stock | Employee Stock Option (Right to Buy) | Disposition | 2019-08-30 | 90,000 | $0.00 | 90,000 | $4.88 |
| Class A Common Stock | Employee Stock Option (Right to Buy) | Disposition | 2019-08-30 | 130,000 | $0.00 | 130,000 | $4.88 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 44,944 | 2019-09-07 | No | 4 | M | Direct | |
| 0 | 2019-09-07 | No | 4 | M | Direct |
Footnotes
- The reporting person acquired 2,500 shares of Class A common stock under the issuer's employee stock purchase plan on June 28, 2019.
- This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
- The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $9.12 to $9.40, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
- This option vested as to 40,000 shares of Class A common stock on each of October 24, 2011, December 21, 2012 and January 4, 2017 upon the issuer's achievement of regulatory or commercial milestones. The remainder of the option expires on September 7, 2019.
- This option, granted as an annual performance award, is presently exercisable in full.
Billionaire Hedge Funds
